Posted inCardiology Critical Care news
Beyond the DanGer Shock Trial: Real-World Outcomes and Risk Stratification in Impella-Treated Patients
This article analyzes recent J-PVAD registry data, evaluating the real-world applicability of the DanGer shock trial criteria and prognostic factors for ECPELLA in acute myocardial infarction-related cardiogenic shock, emphasizing the necessity of individualized risk assessment.